RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.34
-0.66 (-7.33%)
At close: Nov 5, 2025, 4:00 PM EST
9.80
+1.46 (17.51%)
Pre-market: Nov 6, 2025, 8:00 AM EST
RxSight Market Cap
RxSight has a market cap or net worth of $341.24 million as of November 6, 2025. Its market cap has decreased by -82.98% in one year.
Market Cap
341.24M
Enterprise Value
125.29M
1-Year Change
-82.98%
Ranking
Category
Stock Price
$8.34
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $341.24M, a decrease of -19.58%. That is a compound annual growth rate of -4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 341.24M | -75.37% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |